INDACATEROL (Breezhaler®)

Clinical Indication

COPD

Comments

Reviewed by LLR Respiratory Prescribing Group, deemed not appropriate for review by TAS

Date of classification

February 2017

Do not prescribe

Drugs not recommended for use in LLR because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety